Geldenhuys Werner J, Allen David D
Department of Pharmaceutical Sciences, Northeast Ohio Medical University, 4209 State Route 44, Rootstown, OH 44272, USA.
Cent Nerv Syst Agents Med Chem. 2012 Jun;12(2):95-9. doi: 10.2174/187152412800792670.
Drug delivery to the brain is made difficult by the blood-brain barrier (BBB) which is selectively permeable to organic drug compounds. Several membrane solute and nutrient transporters are expressed in the BBB vasculature, which may be utilized as mechanism of delivery of drugs to the brain. Of interest to us, are the organic cation transporters which could be used to transport cationic compounds into the CNS. In this mini-review, we will review the current understanding of the structural requirements for designing compounds which could effectively use organic cation transporters (OCT). For the first time, structural requirements for both OCT1 and OCT2 versus the BBB choline transporter (BBBCHT) are discussed and compared. The information gained here could increase the success rate in successful CNS drug delivery and therapeutics.
血脑屏障(BBB)对有机药物化合物具有选择性通透性,这使得药物向大脑的递送变得困难。几种膜溶质和营养物质转运体在血脑屏障血管系统中表达,它们可被用作将药物递送至大脑的机制。我们感兴趣的是有机阳离子转运体,其可用于将阳离子化合物转运至中枢神经系统(CNS)。在本综述中,我们将回顾目前对于设计可有效利用有机阳离子转运体(OCT)的化合物的结构要求的理解。首次讨论并比较了OCT1和OCT2与血脑屏障胆碱转运体(BBBCHT)的结构要求。在此获得的信息可提高中枢神经系统药物递送和治疗的成功率。